HLA‐G supports immune tolerance,46 and HLA‐E interacts with the natural killer inhibitory receptor KLRD1/NKG2A, which was up‐regulated in all MASLD cases47 (Figure S10C). The gene discussed is KLRC1; the disease is metabolic dysfunction-associated steatotic liver disease.